USNA USANA Health Sciences Inc revenue, earnings and financials
For the quarter ended July 4, 2026, USANA Health Sciences Inc reported revenue of $223M (down 5.3% from a year earlier), net income of −$21.4M and diluted EPS of −$1.16; over the last four quarters revenue was $913M and net income −$22.2M; for the fiscal year ended January 2026 revenue was $925M, up 8.3% on the year before.
USNA annual revenue and earnings
- Fiscal year ended Jan 2026: revenue $925M, gross profit $724M, operating income $37.4M, net income $10.8M (margin 1.2%), EPS $0.58
- Fiscal year ended Dec 2024: revenue $855M, gross profit $693M, operating income $66.3M, net income $42.0M (margin 4.9%), EPS $2.19
- Fiscal year ended Dec 2023: revenue $921M, gross profit $744M, operating income $93.1M, net income $63.8M (margin 6.9%), EPS $3.30
- Fiscal year ended Dec 2022: revenue $999M, gross profit $805M, operating income $108M, net income $69.4M (margin 6.9%), EPS $3.59
- Fiscal year ended Jan 2022: revenue $1.19B, gross profit $969M, operating income $170M, net income $117M (margin 9.8%), EPS $5.73
USNA quarterly revenue and earnings
- Quarter ended Jul 4, 2026: revenue $223M (down 5.3% year over year), net income −$21.4M, EPS −$1.16
- Quarter ended Apr 4, 2026: revenue $250M (up 0.3% year over year), net income $7.52M, EPS $0.41
- Quarter ended Jan 3, 2026 (from the annual report): revenue $226M (up 5.9% year over year), net income −$1.78M, EPS −$0.07
- Quarter ended Sep 27, 2025: revenue $214M (up 6.7% year over year), net income −$6.52M, EPS −$0.36
- Quarter ended Jun 28, 2025: revenue $236M (up 10.8% year over year), net income $9.66M, EPS $0.52
- Quarter ended Mar 29, 2025: revenue $250M (up 9.5% year over year), net income $9.40M, EPS $0.49
- Quarter ended Dec 28, 2024 (from the annual report): revenue $214M (down 3.4% year over year), net income $4.45M, EPS $0.23
- Quarter ended Sep 28, 2024: revenue $200M (down 6.2% year over year), net income $10.6M, EPS $0.56
- Quarter ended Jun 29, 2024: revenue $213M (down 10.6% year over year), net income $10.4M, EPS $0.54
- Quarter ended Mar 30, 2024: revenue $228M (down 8.3% year over year), net income $16.5M, EPS $0.86
- Quarter ended Dec 30, 2023 (from the annual report): revenue $221M (down 3.0% year over year), net income $16.8M, EPS $0.87
- Quarter ended Sep 30, 2023: revenue $213M (down 8.5% year over year), net income $11.3M, EPS $0.59
- Quarter ended Jul 1, 2023: revenue $238M (down 9.9% year over year), net income $17.3M, EPS $0.89
- Quarter ended Apr 1, 2023: revenue $248M (down 9.0% year over year), net income $18.4M, EPS $0.95
- Quarter ended Dec 31, 2022 (from the annual report): revenue $228M (down 14.7% year over year), net income $12.8M, EPS $0.66
- Quarter ended Oct 1, 2022: revenue $233M (down 15.0% year over year), net income $14.9M, EPS $0.78
- Quarter ended Jul 2, 2022: revenue $264M (down 21.5% year over year), net income $19.2M, EPS $1.00
- Quarter ended Apr 2, 2022: revenue $273M (down 11.4% year over year), net income $22.5M, EPS $1.15
- Quarter ended Jan 1, 2022 (from the annual report): revenue $267M, net income $20.3M, EPS $1.05
- Quarter ended Oct 2, 2021: revenue $274M, net income $27.3M, EPS $1.36
USNA cash flow, buybacks and dividends
- Fiscal year ended Jan 2026: operating cash flow $22.3M, share buybacks $27.5M
- Fiscal year ended Dec 2024: operating cash flow $61.0M, share buybacks $9.44M
- Fiscal year ended Dec 2023: operating cash flow $70.6M, share buybacks $11.6M
- Fiscal year ended Dec 2022: operating cash flow $104M, share buybacks $25.4M
- Fiscal year ended Jan 2022: operating cash flow $121M, share buybacks $178M
USNA balance sheet
- Jul 4, 2026: cash $169M, total assets $703M, total liabilities $132M, shareholders' equity $526M
- Apr 4, 2026: cash $163M, total assets $739M, total liabilities $144M, shareholders' equity $544M
- Jan 3, 2026: cash $158M, total assets $743M, total liabilities $157M, shareholders' equity $533M
- Sep 27, 2025: cash $145M, total assets $727M, total liabilities $145M, shareholders' equity $528M
- Jun 28, 2025: cash $151M, total assets $735M, total liabilities $149M, shareholders' equity $531M
- Mar 29, 2025: cash $180M, total assets $747M, total liabilities $163M, shareholders' equity $530M
- Dec 28, 2024: cash $182M, total assets $748M, total liabilities $162M, shareholders' equity $532M
- Sep 28, 2024: cash $365M, total assets $671M, total liabilities n/a, shareholders' equity $533M
What is USNA's revenue?
USANA Health Sciences Inc reported $913M of revenue over its last four quarters, through July 4, 2026.
Is USNA profitable?
No. USANA Health Sciences Inc lost $22.2M over the last four quarters.
What is USNA's EPS?
Diluted earnings per share over the last four quarters were −$1.18; −$1.16 in the latest quarter.